Pular para o conteúdo principal

fms related receptor tyrosine kinase 4

A FLT4 gene provides instructions for making a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. VEGFR-3 is turned on (activated) by two proteins called vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D). When VEGF-C and VEGF-D attach (bind) to VEGFR-3, chemical signals are produced that regulate the growth, movement, and survival of lymphatic cells.

Escolhas de vídeos para Genes
Biblioteca de vídeos

Normal function

A FLT4 gene provides instructions for making a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. VEGFR-3 is turned on (activated) by two proteins called vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D). When VEGF-C and VEGF-D attach (bind) to VEGFR-3, chemical signals are produced that regulate the growth, movement, and survival of lymphatic cells.

Conditions referring to this gene or chromosome

Other names

FLT41

fms-related tyrosine kinase 4

vascular endothelial growth factor receptor 3

VEGFR3

VGFR3_HUMAN

Related patient information and medicines

Câncer de boca

Patient information leaflet

Câncer de boca

O anticorpo monoclonal do receptor do fator de crescimento epidérmico (EGFR mAb) é uma forma de terapia direcionada. Cetuximabe é um EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin.

Leucemia mieloide crônica

Patient information leaflet

Leucemia mieloide crônica

Treatment for the initial chronic phase The aim of treatment is to control the disease process, to ease any symptoms and to prevent (or delay) the progress... You may be advised to have one or more of the following treatments: Imatinib tablets. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Mastocitose e distúrbios de mastócitos

Patient information leaflet

Mastocitose e distúrbios de mastócitos

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on ... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new guidance on the use of midostaurin for people with mastocytosis..

Fibromialgia

Patient information leaflet

Fibromialgia

Fibromialgia é a condition which causes pain and tenderness in the muscles and soft tissues in different areas of the body, associated with unrefreshing sleep and physical tiredness. The word fibromialgia means pain (-algia) coming from the muscles (my-) and fibrous tissues (fibro-) such as tendons and ligaments. Due to its wide range of.

Degeneração macular

Patient information leaflet

Degeneração macular

It is more common with increasing age. It is rare under the age of 60. It usually begins in one eye. About 5 in 100 people aged over 65 and about 12 in 100 people aged over 80 have AMD severe enough to cause serious visual impairment. Women are more likely than men to develop AMD. White people are more likely to develop AMD than those of African.

Testes de função hepática

Patient information leaflet

Testes de função hepática

They include substances that are made in the liver or affected by the health of the liver cells, chemicals which are processed or excreted by the liver, and hormones that the liver makes. What are liver function tests used for. Liver function tests are aimed at giving a picture of the 'state' of your liver. They are a sensitive way of looking for.

Leitura adicional e referências

Histórico do artigo

As informações nesta página são escritas e revisadas por clínicos qualificados.
  • 28 Jun 2022 | Última versão
  • 1 May 2008 | Publicado originalmente

Participe da conversa

Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.

Aviso: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmácia online, tratamentos e serviços de saúde

Acesso simples a tratamentos confiáveis e serviços de saúde online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscreva-se no boletim informativo do Patient

Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.

Por favor, insira um endereço de e-mail válido

Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.